A phase I safety study in healthy adults confirmed that subcutaneous MOTS-c injections at doses up to 10 mg produced no serious adverse events, with a pharmacokinetic profile supporting once-daily or every-other-day dosing [3]
The gap between doing it right and doing it wrong comes down to three variables most guides never mention: lyophilised peptide purity percentage, bacteriostatic water volume, and the molecular weight correction factor for 5-Amino-1MQ hydrochloride salt versus free base
This requires proper training on injection technique, storage, handling, and disposal of supplies
Some users have taken 1mg daily for severe injuries without reporting major issues, and others have used even more
BPC 157 and its possible use in therapy
Its half-life is around 5 days, which means it remains at stable levels between doses, and the time of day you inject will not impact its effectiveness